Picture of AFC-HD AMS Life Science Co logo

2927 AFC-HD AMS Life Science Co Income Statement

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedSmall CapTurnaround

Annual income statement for AFC-HD AMS Life Science Co, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.

2019
August 31st
2020
August 31st
2021
August 31st
C2022
August 31st
2023
August 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue16,25315,81922,36823,02525,579
Cost of Revenue
Gross Profit4,5214,5556,8658,5839,323
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses15,29114,82120,12622,11824,051
Operating Profit9629992,2429071,528
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes1,0911,0042,1581,2351,546
Provision for Income Taxes
Net Income After Taxes7836771,4957381,107
Minority Interest
Net Income Before Extraordinary Items
Net Income7836771,4967351,103
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income7836771,4967351,103
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS51.852.710967.595.4
Dividends per Share
Special Dividends per Share